| Application no. and date | 02780622.3 (espacenet) (Federated) (European Patent Register), 20021112 | | Patent/reg. no. and date | DK/EP 1446379, 20090429 | | Publication date | 20040818 | | Priority no. and date | US 338194 P, 20011113, US 343771 P, 20011228 | | EP pub. no. and date |
EP 1446379 20040818 | | Effective date | | | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | 135959 | | Inventor | MORAN, Edmund, J., 131 Chaves
San Francisco, CA 94127, US,
JACOBSEN, John, R., 16 Oak Valley Road
San Mateo, CA 94402, US,
LEADBETTER, Michael, R., 335 Beverly Avenue
San Leandro, CA 94577, US,
TRAPP, Sean, G., 1112 De Haro
San Francisco, CA 94107, US,
CHURCH, Timothy, J., 3913 Pasadena Drive
San Mateo, CA 94403, US,
AGGEN, James, 1311 California Drive
Burlingame, CA 94010, US,
NODWELL, Matthew, B., No. 8, 1346 Cotton Drive
Vancouver, BC V5L 3T7, CA | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07C 229/60 (2006.01) | | Title | Arylanilin-beta2-adrenergiske receptoragonister | | Int. application no. | US2002036237 | | Int. publication no. | WO2003042164 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
